Novo Nordisk Sees First-Half U.S. Launch of Tresiba

Jan. 31 (Bloomberg) -- Jesper Brandgaard, chief financial officer of Novo Nordisk A/S, discusses the company's fourth-quarter profit reported today, growth expectations for the insulin market and the outlook for U.S. approval of its Tresiba diabetes treatment. He speaks from Copenhagen with Francine Lacqua on Bloomberg Television's "The Pulse." (Source: Bloomberg)

Creating a One-Stop Shop for A.I. Integration
32:25 - Businesses of all stripes are doing their best to integrate big data, artificial intelligence and machine learning into their workflows. Optix Solutions is trying to take the stress out of the transition. Globalive Chairman Anthony Lacavera asks Spencer Fung, founder and CEO of Optix Solutions, about the objective behind the company. (Source: Bloomberg)
  • Finding the Perfect Words to Reel in Top Talent
  • Exploring the World Through Panoramic Photos
  • Full Show: What'd You Miss? (04/28)